JP Patent

JP6818019B2 — レファムリンの注射可能医薬組成物

Assigned to ナブリヴァ セラピュティクス ゲーエムベーハー · Expires 2021-01-20 · 5y expired

What this patent protects

Patent listed against fosaprepitant-dimeglumine.

Drugs covered by this patent

Patent Metadata

Patent number
JP6818019B2
Jurisdiction
JP
Classification
—
Expires
2021-01-20
Drug substance claim
No
Drug product claim
No
Assignee
ナブリヴァ セラピュティクス ゲーエムベーハー
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.